Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lo

Showing results (421-430 of 437) with videos related to

Pageof 44
Sort By:
Osteoarthritis and Cartilage|March 9, 2023
Evaluating Osteoarthritis Management Programs: outcome domain recommendations from the OARSI Joint Effort InitiativeK D Allen, K Huffman, R J Cleveland, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
Liver Cancer|July 8, 2016
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular CarcinomaPierce K H Chow, Su Pin Choo, David C E Ng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2021
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trialM Annala, S Fu, J V W Bacon, et al.
Infection|October 24, 2013
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patientsM T Montagna, G Lovero, C Coretti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2023
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic reviewA Prelaj, V Miskovic, M Zanitti, et al.
Liver Cancer|April 21, 2025
The Impact of Radiation Dose and Tumour Burden on Outcomes in Hepatocellular Carcinoma: 11-Year Experience in a 413-Patient Cohort Treated with Yttrium-90 Resin Microsphere RadioembolisationKaina Chen, Aaron K T Tong, Fiona N N Moe, et al.
World Journal of Surgery|March 7, 2013
Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trialA Y F Chung, L L P J Ooi, D Machin, et al.
Physical Review Letters|January 15, 2011
Discovery of the shape coexisting 0+ state in 32 Mg by a two neutron transfer reactionK Wimmer, T Kröll, R Krücken, et al.
ESMO Open|March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancerG L Banna, A Cortellini, D L Cortinovis, et al.
Pageof 44

Showing results (421-430 of 437) with videos related to

Sort By:
Pageof 44
Osteoarthritis and Cartilage|March 9, 2023
Evaluating Osteoarthritis Management Programs: outcome domain recommendations from the OARSI Joint Effort InitiativeK D Allen, K Huffman, R J Cleveland, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
Liver Cancer|July 8, 2016
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular CarcinomaPierce K H Chow, Su Pin Choo, David C E Ng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2021
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trialM Annala, S Fu, J V W Bacon, et al.
Infection|October 24, 2013
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patientsM T Montagna, G Lovero, C Coretti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2023
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic reviewA Prelaj, V Miskovic, M Zanitti, et al.
Liver Cancer|April 21, 2025
The Impact of Radiation Dose and Tumour Burden on Outcomes in Hepatocellular Carcinoma: 11-Year Experience in a 413-Patient Cohort Treated with Yttrium-90 Resin Microsphere RadioembolisationKaina Chen, Aaron K T Tong, Fiona N N Moe, et al.
World Journal of Surgery|March 7, 2013
Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trialA Y F Chung, L L P J Ooi, D Machin, et al.
Physical Review Letters|January 15, 2011
Discovery of the shape coexisting 0+ state in 32 Mg by a two neutron transfer reactionK Wimmer, T Kröll, R Krücken, et al.
ESMO Open|March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancerG L Banna, A Cortellini, D L Cortinovis, et al.
Pageof 44